India’s First Dengue Vaccine Gets Green Signal; DCGI Grants Approval

India has granted the green signal to its first dengue vaccine. The subject expert committee of the Drugs Controller General of India (DCGI) has approved the vaccine, marking a significant step forward in dengue prevention in the country.

The vaccine, developed by Japan-based Takeda Pharmaceutical Company, is known as Qdenga (TAK-003). It is recommended for individuals aged between 4 and 60 years and is administered in two doses with a three-month interval, according to officials.